News

Biotechnology company Regeneron buying 23andMe for US$256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for US$256 million, two months after the genetic testing ...
Global shares slide, Wall Street futures drop after Moody’s downgrade of U.S. credit rating
Global shares fell Monday and U.S. futures and the U.S. dollar also weakened after Moody’s Ratings downgraded the sovereign ...
Tariffs, economic uncertainty chilling cottage housing market, report says
The May long weekend marks the unofficial start of cottage season for many Canadians, but a new report says some looking to ...